As an experienced trader, I approach every broker with a careful eye on regulatory status, product scope, and practical features. When evaluating Tracom, I found that its main advantage lies in the breadth of its investment instruments. This broker offers access to capital markets, demat services, mutual funds, portfolio management (PMS) distribution, initial public offerings (IPO) application, and various types of bonds, including NCDs, corporate fixed deposits, RBI bonds, and capital gains tax savings bonds. For someone like me who values diversification, this variety is attractive, as it allows a single account to manage equities, debt instruments, and mutual funds. However, I must emphasize that Tracom operates without any valid regulatory license. In my experience, this raises significant concerns around client fund safety and transparency—especially when compared to brokers who are stringently regulated and scored much higher on industry trust metrics. Also, there was no clear public information about Tracom’s fee model, nor does the broker offer demo accounts for trial purposes. This lack of transparency around fees and trading costs makes it difficult to assess competitiveness, and can be a risk for traders who are conscious about costs. While the broad product access is notable, caution is essential due to the unregulated nature and opaque fee structure—I personally would avoid entrusting significant funds to any broker under these circumstances.